The National Health Commission has released a Q&A on the centralized rectification of corruption in the pharmaceutical industry nationwide
Today, the National Health Commission issued a Q&A on the centralized rectification of corruption in the national pharmaceutical industry.
1、 What is the background and purpose of carrying out centralized rectification work?
Answer: The pharmaceutical field is the main battlefield for maintaining the health of the people, and it is related to the most concerned, direct, and practical health rights and interests of the general public. The Central Committee of the Communist Party of China attaches great importance to the high-quality development of the pharmaceutical industry and prioritizes the protection of people's health as a strategic priority for development. Since the 18th National Congress of the Communist Party of China, the medical and health industry has focused on major diseases and major issues that affect people's health, accelerated the implementation of the Healthy China strategy, promoted the sustained high-level development of medicine, medical care, and medical insurance, and promoted the expansion of high-quality medical resources and regional balanced layout. Medical workers bear the sacred responsibility of saving lives, helping the injured, and maintaining the health of the people. For a long time, medical personnel have responded to the call of the Party and practiced the new era professional spirit of "respecting life, saving lives and helping the injured, willing to contribute, and loving the boundless". They have played an irreplaceable important role in disease prevention, diagnosis, treatment, rehabilitation nursing, medical technology innovation and development, and achieved fruitful results, which have been understood, supported, and respected by the whole society. The hard work and dedication of medical workers should be fully recognized.
Strengthening anti-corruption work in the pharmaceutical industry is an important part of promoting high-quality development and improving the construction of the pharmaceutical governance system. For many years, the National Health Commission, as the leading unit of the inter ministerial joint mechanism to correct improper practices in the field of pharmaceutical purchasing and sales and medical services, has continuously strengthened the construction of industry style in conjunction with relevant departments. It has combined system construction, institutional construction, and the implementation of the nine guidelines for clean and honest employment, resolutely corrected industry misconduct, and achieved significant improvements. With the historic achievements in comprehensive strict governance of the Party, the construction of Party conduct and clean governance, and the fight against corruption, the industry atmosphere in the pharmaceutical industry continues to improve. However, at the same time, corruption in the pharmaceutical industry still exists, especially in recent years when some "key minority" and key position personnel have been investigated and punished for using their power to seek rent, accepting kickbacks, bribery and other cases, seriously diluting the dividends of the reform and development of the pharmaceutical industry, eroding the rights and interests of the people, hindering the reform and development of the medical, medical insurance, and pharmaceutical industries, affecting the industry image, and harming the interests of the vast majority of people in the medical and health field.
In order to further promote the development and progress of the pharmaceutical industry, safeguard the health rights and interests of the people, the National Health Commission, together with the Ministry of Education, the Ministry of Public Security, the National Audit Office, the State owned Assets Supervision and Administration Commission of the State Council, the State Administration for Market Regulation, the National Medical Insurance Administration, the National Administration of Traditional Chinese Medicine, the National Bureau of Disease Control and Prevention, and the National Medical Products Administration, has jointly launched a one-year centralized rectification work on corruption in the pharmaceutical industry. With a problem oriented approach, the National Health Commission focuses on the "key minority" and key positions in the pharmaceutical industry, resolutely crack down on violations, discipline, and illegal activities, and build a clean and upright industry atmosphere to provide guarantees for the high-quality development of the pharmaceutical and health.
2、 What are the main principles to consider in carrying out the centralized rectification work this time?
Answer: Currently, the difficulty of rectifying corruption in the pharmaceutical industry is increasing, and it is necessary for all departments involved in the entire pharmaceutical procurement and sales chain to enhance their collaborative efforts and carry out joint governance. It is necessary to implement the concept of systematic governance throughout the work. Therefore, this concentrated rectification work has clarified three working principles:
One is to comprehensively cover and focus on key areas. This rectification covers the entire chain of production, circulation, sales, use, and reimbursement in the pharmaceutical industry, as well as administrative departments, industry associations, medical and health institutions, pharmaceutical production and operation enterprises, medical insurance funds, and other fields in the pharmaceutical field, achieving full coverage in the pharmaceutical field. In the focus of rectification, we will focus on "key minority" and key positions, especially illegal behaviors such as using power in the pharmaceutical industry to seek rent, "selling with money", and transferring benefits.
The second is to focus on breakthroughs and simultaneously carry out rectification and construction. Key breakthroughs will be made in addressing the issue of corruption in key minority and key positions. Key issues and typical cases will be investigated, verified, dealt with, and analyzed through notification, forming a high-pressure situation of nationwide centralized rectification of corruption in the pharmaceutical industry. Adhere to the combination of clue handling, problem rectification, and industry governance, improve rules and regulations, governance mechanisms, and regulate industry supervision, pay attention to strengthening the construction of long-term mechanisms, and achieve systematic, standardized, and normalized governance of corruption in the pharmaceutical industry.
The third is unified implementation and hierarchical responsibility. Strictly implement work responsibilities and ensure that all requirements and tasks of centralized rectification work are implemented and effective. Under the unified leadership of the collaborative mechanism for the centralized rectification of corruption in the national pharmaceutical industry, relevant functional departments and local governments shall effectively assume the main responsibility for the centralized rectification, and shall be responsible at different levels to ensure effective implementation. The institutions and units included in the scope of rectification shall bear direct responsibility, be responsible for implementing the specific requirements of the superior supervisory department for centralized rectification work, and strictly implement the various tasks of centralized rectification work.
This concentrated rectification will follow the above principles to carry out systematic governance of the entire chain, all fields, and all coverage of the pharmaceutical industry, solve systemic problems in industry supervision, solidly promote industry governance in the pharmaceutical field, and ensure the effectiveness of the rectification work.
3、 What are the key contents and measures for carrying out centralized rectification in response to the current corruption problems in the pharmaceutical industry?
Answer: The focus of this concentrated rectification is on six aspects: first, the administrative management departments in the pharmaceutical industry are seeking rent through their power; The second is the "key minority" and key positions within medical and health institutions, as well as the "gold sales" of drugs, equipment, consumables, and other aspects; Thirdly, social organizations that receive guidance from administrative departments in the field of medicine utilize their work convenience to seek benefits; The fourth is related to the use of medical insurance funds; The fifth is the illegal behavior of pharmaceutical production and operation enterprises in the field of purchase and sales; Sixth, medical personnel violate the Nine Guidelines for Clean and Honest Employment of Medical Institution Staff. By taking measures such as self-examination and self correction, centralized rectification, and summary rectification, we will carry out comprehensive and comprehensive systematic governance of prominent corruption issues in the pharmaceutical industry, establish and improve a series of long-term mechanisms, and ensure the effectiveness of our work.
4、 What progress has been made since the deployment of the centralized rectification work, and what are the plans for the next steps?
Answer: In early July of this year, the National Health Commission, together with nine departments, jointly issued relevant documents, focusing on solving the prominent problem of corruption in the current pharmaceutical industry, as well as the key links that are prone to problems in the entire chain of pharmaceutical procurement, sales, and medical services. They clarified the overall requirements, rectification content, work steps, and work requirements of this centralized rectification. On July 12th, the National Health Commission and 10 other departments held a video conference on the centralized rectification of corruption in the pharmaceutical industry nationwide. The conference focused on key links and "key minorities" in the production, supply, sales, use, and reimbursement of the pharmaceutical industry, and focused on the centralized rectification work. More than 4000 people from various regions and departments attended the conference. On July 28th, the Central Commission for Discipline Inspection and the National Supervisory Commission held a video conference to cooperate in carrying out centralized rectification work, focusing on "key minorities" in the pharmaceutical field, strengthening supervision, discipline enforcement, and law enforcement, and deploying it within the disciplinary inspection and supervision system. At the same time, the National Health Commission launched the "Internet plus" business climate review platform on the home page of the official website, establishing and unblocking information communication channels for the society.
According to the work deployment, each province has established a collaborative mechanism for the centralized rectification of corruption in the field of local medicine, formulated and issued local work plans, and held meetings to make deployment arrangements. Relevant units in various regions have rapidly carried out self-examination and self correction, dealt with relevant issues, published multiple cases, and formed a strict tone and atmosphere. Anti corruption has formed a broad consensus in the pharmaceutical industry, and various centralized rectification work is steadily progressing.
The next step is to continuously promote the centralized rectification work according to the overall arrangement, increase guidance and scheduling of the work, increase the handling and notification of typical problems, and ensure the effectiveness of the rectification work.
5、 Is it a requirement for concentrated rectification to announce the suspension or postponement of some academic conferences due to the recent anti-corruption situation?
We have noticed that some academic conferences have been announced to be suspended or postponed in response to the anti-corruption situation in the pharmaceutical industry, as reported by the media. However, we have also learned that some academic conferences are proceeding normally and have not been affected. Academic conferences in the pharmaceutical industry are important platforms for academic exchange, experience sharing, and promotion of pharmaceutical technology progress and innovative development. In accordance with relevant national regulations, standardized academic conferences and normal medical activities should be strongly supported and actively encouraged. What needs to be rectified are those who fabricate false academic conference titles, engage in illegal and irregular benefit transmission, or illegally divide academic conference sponsorship fees.
6、 Recently, there have been corruption cases online, such as "Xu Bo from Fuwai Hospital" and "Jiangsu Changzhou Breast Surgery Expert". Are their contents true?
We are following the relevant information that appears online. After investigation, it was found that Xu Bo, the director of the Interventional Catheter Room at Fuwai Hospital of the Chinese Academy of Medical Sciences, was investigated and investigated by the Discipline Inspection and Supervision Group of the Central Commission for Discipline Inspection and the National Supervisory Commission stationed at the National Health Commission and the Changzhi Municipal Supervisory Commission in Shanxi Province on suspicion of serious violations of discipline and law. At present, the case is still being processed. After communication and consultation with the case handling department, it was reported online that the information about him accepting bribes of up to 1.2 billion yuan by taking advantage of the opportunity to undergo surgery, purchase consumables, and participate in medical equipment procurement bidding is seriously inconsistent with the current situation of the case investigation and is false information.
Regarding the information that "Zhu, a famous breast surgery expert in Changzhou, was arrested and a total of 150 million were found at home," the local authorities have explained through mainstream media in Changzhou about the false information spread online.
